The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases.
D000818:Animals; D001927:Brain Diseases / Q000150:complications*; D002415:Cats; D002819:Chorea / Q000139:chemically induced / Q000209:etiology; D005116:Extrapyramidal Tracts; D005917:Globus Pallidus / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D008636:Mesencephalon / Q000502:physiology; D009069:Movement Disorders / Q000139:chemically induced / Q000209:etiology; D009132:Muscles / Q000503:physiopathology; D010300:Parkinson Disease / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D011618:Psychotic Disorders / Q000188:drug therapy; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy; D013378:Substantia Nigra / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced / Q000209:etiology
D014149:Tranquilizing Agents